| Literature DB >> 22210593 |
Daniel J Ludeman1, Bryan G Schwartz, Steven Burstein.
Abstract
The Impella LP 2.5 left ventricular assist device (Abiomed) is safe and effective for assisting high-risk percutaneous interventions. A 77-year-old woman with severe aortic stenosis, severe coronary artery disease, an ejection fraction of 20%, severe peripheral vascular disease, and other comorbidities presented to a private, tertiary referral hospital with shortness of breath that had been worsening over 2 weeks. The patient underwent a successful, Impella-assisted balloon aortic valvuloplasty (BAV) without complications. Impella support may be considered during BAV in high-risk patients with contraindications for a TandemHeart device (CardiacAssist, Inc.).Entities:
Mesh:
Year: 2012 PMID: 22210593
Source DB: PubMed Journal: J Invasive Cardiol ISSN: 1042-3931 Impact factor: 2.022